• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 0.00% 61.0¢

RECCE PHARMACEUTICALS LTD

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE UPDATE HIGHLIGHTS KEY DEVELOPMENTS FOR UPSIDE

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RCE 14:31 14 5.1K
14:31 Last post  zecs Comments Created with Sketch.  14  Views Created with Sketch.  5.1K 
RCE 15/05/24 5 1.1K
15/05/24 Last post  hatmopit Comments Created with Sketch.  5  Views Created with Sketch.  1.1K 
RCE 14/05/24 51 18K
Metals & Mining SECTOR NEWS

Meet Sun Silver (ASX:SS1) - ASX's newest silver player based in Nevada, USA.

SS1
16 May 2024
SUN SILVER LIMITED
14/05/24 Last post  bcr Comments Created with Sketch.  51  Views Created with Sketch.  18K 
RCE 12/05/24 19 4.3K
12/05/24 Last post  Rykster Comments Created with Sketch.  19  Views Created with Sketch.  4.3K 
RCE 10/05/24 0 266
10/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 
RCE 10/05/24 0 294
10/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  294 
RCE
[INTERVIEW] Recce gearing up for Indonesian trials
10/05/24 47 13K
10/05/24 Last post  bevel19 Comments Created with Sketch.  47  Views Created with Sketch.  13K 
RCE
Recce Pharma has been featured in the latest Thematic Insights Report - Download now!
08/05/24 0 226
08/05/24 Last post  TheMarketOnline Comments Created with Sketch.  0  Views Created with Sketch.  226 
RCE 08/05/24 7 1.8K
08/05/24 Last post  maccaone Comments Created with Sketch.  7  Views Created with Sketch.  1.8K 
RCE 06/05/24 51 13K
06/05/24 Last post  Lucretious Comments Created with Sketch.  51  Views Created with Sketch.  13K 
RCE 27/04/24 7 2.8K
27/04/24 Last post  BelowAverage Comments Created with Sketch.  7  Views Created with Sketch.  2.8K 
RCE 23/04/24 4 2.1K
23/04/24 Last post  Lucretious Comments Created with Sketch.  4  Views Created with Sketch.  2.1K 
RCE 17/04/24 2 913
17/04/24 Last post  BelowAverage Comments Created with Sketch.  2  Views Created with Sketch.  913 
RCE 19:23 0 304
19:23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  304 
RCE 11/04/24 22 8.3K
11/04/24 Last post  The Ace Comments Created with Sketch.  22  Views Created with Sketch.  8.3K 
RCE 06/04/24 8 3.2K
06/04/24 Last post  MongooseMan Comments Created with Sketch.  8  Views Created with Sketch.  3.2K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Timeline

Ph I/II UTI/Urosepsis Trial Dosing Commenced in Next Cohort
15 May 11:46
 
Cleansing Statement
10 May 18:14
 
Application for quotation of securities - RCE
10 May 18:06
 
MCRI Pilot Study- Positive Efficacy Data for Lung Infections
09 May 12:31
 
China Patent Granted for RECCE Anti-Infectives
07 May 08:38
 
Safety Committee Approves High Dose of 4,000mg
26 Apr 09:42
 
View More arrow Created with Sketch.
(20min delay)
Last
61.0¢
Change
0.000(0.00%)
Mkt cap ! $124.4M
Open High Low Value Volume
62.0¢ 62.0¢ 60.0¢ $14.69K 24.34K

Buyers (Bids)

No. Vol. Price($)
1 3915 60.0¢
 

Sellers (Offers)

Price($) Vol. No.
61.0¢ 305 1
View Market Depth
Last trade - 16.10pm 16/05/2024 (20 minute delay) ?
Last
62.0¢
  Change
0.000 ( 0.80 %)
Open High Low Volume
62.5¢ 62.5¢ 60.5¢ 50
Last updated 14.46pm 16/05/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.